Medical Linear Accelerator Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Medical Linear Accelerator Market is segmented By Product Type (Dedicated Linear Accelerator, Non-Dedicated Linear Accelerator), By Treatment Type and Geography.

Medical Linear Accelerator Market Snapshot

Medical Linear Accelerator Market
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 8.2 %
Medical Linear Accelerator Market Size

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Medical Linear Accelerator Market is expected to register a CAGR of 8.2% during the forecast period. High prevalence of cancer and technological advancements in product is expected to drive the medical linear accelerator market growth. According to Cancer Research UK, approximately 17 million people were diagnosed with cancer globally in 2018. Moreover, most cancers are diagnosed at the last stage of it. Hence, as the incidence of cancer is increasing the demand for treatment will also increase and thereby expected to boost the medical linear accelerator market growth. 

Scope of the Report

A medical linear accelerator uses X-rays of high energy and takes the shape of tumor to destroy it while leaving the healthy cells. It is commonly practiced in external radiotherapy. Medical Linear Accelerator Market is segmented By Product Type, Treatment Type and Geography.

By Product Type
Dedicated Linear Accelerator
Non-Dedicated Linear Accelerator
By Treatment Type
Intensity Modulated Radiation Therapy
Volumetric Modulated Arc Therapy
Image Guided Radiation Therapy
Stereotactic Radiosurgery/Stereotactic Body Radiotherapy
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Stereotactic Radiosurgery /Stereotactic Body Radiotherapy Segment is Expected to Hold a Major Market Share in the Medical Linear Accelerator Market

  • Stereotactic radiosurgery and steretactic body radiotherapy is a type of external radiotherapy that uses high energy photons to destroy cancerous cells while sparing healthy cells. Linear accelerator based stereotactic radiosurgery is rapidly increasing for the treatment in cancer and other neurological disorder such as trigeminal neurolagia.
  • One of the study published in 2017, by Journal of Applied Clinical Medical Physics revealed that linear accelerator based stereotactic surgery was found to be very effective in case of trigeminal neuralgia. Furthermore, with the wide accepentance of non-invasive surgery, the market is expected to increase.
 Medical Linear Accelerator Market Share

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the global medical linear accelerator market due to growing burden of diseases such as cancer and trigeminal neuralgia. According to Trigeminal Neuralgia Association of Canada, almost each year 5 per 100,000 people are diagnosed with trigeminal neuralgia in Canada. Furthermore, according to National Organization for Rare Disorders, trigeminal neuralgia is affecting between 10,000 to 15,000 people each year in the United States. One of its treatment include stereotactic surgery by using modified linear accelerator. Thus, these factors are expected to propel the medical linear accelerator market growth in North America.

Medical Linear Accelerator Market Trends

Competitive Landscape

The Medical Linear Accelerator Market is consolidated and consists of several major players. Companies are collaborating to develop the linear accelerators. For instance, in 2018, Elekta AB received it USFDA approval for its Elekta Unity, MR-linac (linear accelerator). It is used for mainly treating cancer by personalized radiation therapy. Some of the major players in the market are Panacea Medical Technologies, Accuray Inc., Viewray Technologies Inc., Elekta AB, Siemens Healthcare and Shinva Medical Instrument Co. Ltd., 

Recent Development

In April 2021, Varian, a Siemens Healthineers company, an agreement with Australia’s Icon Group to provide 30 linear accelerators and associated treatment software to help tackle the growing global cancer burden. This agreement further strengthens the global partnership between Varian and Icon Group, together increasing access to care across regional and underserviced areas in Australia and Asia.

In June 2020, Teledyne e2v US, a business unit of Teledyne Digital Imaging US, Inc., appointed RS&A Inc, United States based independent service provider of medical equipment, as its distributor of its linear accelerator medical and industrial products in the Americas.

Table of Contents


    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Burden of Cancer Diseases

      2. 4.2.2 Advancement in Product Development

    3. 4.3 Market Restraints

      1. 4.3.1 Shortage of Trained Professionals

      2. 4.3.2 Stringent Regulatory Framework

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product Type

      1. 5.1.1 Dedicated Linear Accelerator

      2. 5.1.2 Non-Dedicated Linear Accelerator

    2. 5.2 By Treatment Type

      1. 5.2.1 Intensity Modulated Radiation Therapy

      2. 5.2.2 Volumetric Modulated Arc Therapy

      3. 5.2.3 Image Guided Radiation Therapy

      4. 5.2.4 Stereotactic Radiosurgery/Stereotactic Body Radiotherapy

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Accuray Inc.

      2. 6.1.2 Elekta AB

      3. 6.1.3 Shinva Medical Instrument Co. Ltd.

      4. 6.1.4 Siemens Healthcare

      5. 6.1.5 Viewray Technologies Inc.

      6. 6.1.6 Brainlab AG

      7. 6.1.7 Panacea Medical Technologies Pvt Ltd.

      8. 6.1.8 Altair Technologies Inc.

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Medical Linear Accelerator Market market is studied from 2019 - 2027.

The Medical Linear Accelerator Market is growing at a CAGR of 8.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Accuray Inc., Elekta AB , Viewray Technologies, Inc. , Shinva Medical Instruments Co. Ltd. , Panacea Medical Technologies Pvt. Ltd. are the major companies operating in Medical Linear Accelerator Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!